Laboratoires (ALEMG) | Stock Overview & Key Data
Laboratoires Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €28.40 on February 24, 2020
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Laboratoires
ALEMG
|
13.88M Small-cap | -1.20% | -1.20% | 4.88% | 25.70% | 26.02% | 18.07% | 8.41% | -70.23% | -17.37% | 0.00% | 0.00% |
| 182.02M Mid-cap | 3.14% | -9.87% | 3.14% | -1.00% | 3.35% | -19.76% | -22.66% | -52.13% | 25.60% | 265.12% | 265.12% | |
|
Metrics In Balance
MLMIB
|
144.89K Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -90.00% | -97.93% | -99.50% | -99.50% | -99.50% |
|
TheraVet S.A
ALVET
|
N/A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -89.74% | -98.11% | -99.02% | -99.02% | -99.02% | -99.02% |
|
Sanofi
SAN
|
N/A | -1.47% | 2.14% | -7.77% | -7.77% | -7.77% | -6.59% | -6.59% | -6.59% | -6.59% | -6.59% | -6.59% |
| 88.12B Large-cap | 6.30% | 6.23% | -6.90% | -6.90% | -6.90% | -6.21% | -6.21% | -6.21% | -6.21% | -6.21% | -6.21% |
Ownership & Short Interest
Calculate Your Laboratoires Investment Returns
Long-Term Investment Performance Analysis
Laboratoires stock price in Jul 2016 was €5.94, A €1,000.00 lump sum investment in Laboratoires made 9 years ago would be worth approximately €831.65 today, representing a negative return of -16.84%. This translates to an annualized return (CAGR) of -1.84%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ALEMG's 52-week high and low?
- In the last 52 weeks, Laboratoires reached a high of €6.15 (on May 11, 2026) and a low of €3.80 (on October 3, 2025).
- What is the market cap and P/E ratio for ALEMG?
- Curious about Laboratoires's size and valuation? Its market capitalization stands at 13.88M. When it comes to valuation, the P/E ratio (trailing twelve months) is 12.79, and the forward P/E (looking ahead) is 11.14.
- Does ALEMG pay dividends? If so, what's the yield?
- As for dividends, Laboratoires isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Laboratoires's main competitors or similar companies to consider before investing?
When looking at Laboratoires, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Bastide le Confort
BLC182.02M Healthcare Medical Distribution -19.76% -22.66% Metrics In Balance
MLMIB144.89K Healthcare Medical Distribution 0.00% -90.00% TheraVet S.A
ALVETN/A Healthcare Biotechnology -89.74% -98.11% Sanofi
SANN/A Healthcare Drug Manufacturers - General -6.59% -6.59% EssilorLuxottica
EL88.12B Healthcare Medical Instruments & Supplies -6.21% -6.21% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Laboratoires Euromedis S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Laboratoires's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -28.35%, the Debt to Equity ratio from the most recent quarter is 50.72, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALEMG?
- Looking at Laboratoires's growth, its revenue over the trailing twelve months (TTM) was €39M. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.00%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALEMG stock is held by insiders and institutions?
- Wondering who owns Laboratoires stock? Company insiders (like executives and directors) hold about 64.06% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 2.02%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.